Myxoma virus and oncolytic virotherapy: a new biologic weapon in the war against cancer

Author： Stanford Marianne M   McFadden Grant  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.7, Iss.9, 2007-09, pp. : 1415-1425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Future directions for the field of oncolytic virotherapy: a perspective on the use of vaccinia virus

By Thorne Steve H   Kirn David H  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 8, 2004-08 ,pp. : 1307-1321

Informa Healthcare

Access to resources Recommend Favorite

Oncolytic virotherapy for multiple myeloma

By Stief Amaalia E   McCart J Andrea  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 4, 2008-04 ,pp. : 463-473

Informa Healthcare

Access to resources Recommend Favorite

Oncolytic vaccinia virus for the treatment of cancer

By Guse Kilian   Cerullo Vincenzo   Hemminki Akseli  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 5, 2011-05 ,pp. : 595-608

Informa Healthcare

Access to resources Recommend Favorite

Oncolytic virotherapy for cancer with the adenovirus dl1520 (Onyx-015): results of Phase I and II trials

By Kirn D.  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 3, 2001-05 ,pp. : 525-538

Informa Healthcare

Access to resources Recommend Favorite

Targeting autophagy to enhance oncolytic virus-based cancer therapy

By Meng Songshu  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 6, 2013-08 ,pp. : 863-873

Informa Healthcare

Access to resources Recommend Favorite